Business
NHI Announces First Quarter 2025 Results
MURFREESBORO, TN / ACCESS Newswire / May 5, 2025 / National Health Investors, Inc. (NYSE:NHI) announced today its results for the three months ended March 31, 2025. Financial Results and Recent Events Net income attributable to common stockholders ...
About this update from National Health Investors, Inc.
[{"type":"text","content":"MURFREESBORO, TN / ACCESS Newswire / May 5, 2025 / National Health Investors, Inc. (NYSE:NHI) announced today its results for the three months ended March 31, 2025.","length":164,"tagName":"p"},{"type":"text","content":"Financial Results and Recent Events","length":35,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Net income attributable to common stockholders per diluted common share for the three months ended March 31, 2025 was $0.74 compared to $0.71 during the same period in the prior year. Net income attributable to common stockholders for the three months ended March 31, 2025 includes approximately $0.3 million in proxy contest and related expenses for a proxy campaign associated with the Company's 2025 annual stockholders meeting and approximately $1.2 million in transaction costs described in greater detail below.","length":521,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":521,"olType":false},{"type":"list","items":[{"val":[{"type":"text","content":"National Association of Real Estate Investment Trusts ("NAREIT") FFO per diluted common share was $1.14 for the three months ended March 31, 2025 compared to $1.10 during the same period in the prior year. NAREIT FFO for the three months ended March 31, 2025 includes approximately $0.3 million in proxy contest and related expenses and approximately $1.2 million in transaction costs.","length":395,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":395,"olType":false},{"type":"list","items":[{"val":[{"type":"text","content":"Normalized FFO per diluted common share for the three months ended March 31, 2025 was $1.15 compared to $1.12 during the same period in the prior year. Normalized FFO for the three months ended March 31, 2025 includes approximately $1.2 million in transaction costs.","length":266,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":266,"olType":false},{"type":"list","items":[{"val":[{"type":"text","content":"Normalized FAD for the three months ended March 31, 2025 was $56.0 million compared to $51.0 million during the same period in the prior year.","length":142,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":142,"olType":false},{"type":"list","items":[{"val":[{"type":"text","content":"Net income attributable to common stockholders, NAREIT FFO, Normalized FFO and Norma...